Holen Sie sich die Stockscreener-App
2.09
5.43%
-0.12
Handel nachbörslich:
2.20
0.11
+5.26%
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
PCSA Q4 2025 Earnings: EPS Misses Estimates by 67.97% as Pre-Revenue Biotech Faces HeadwindsWeak Earnings Momentum - newsline.com
Processa Pharmaceuticals, Inc. - MLQ.ai
PCSA Stock Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
PCSA Stock Price, Quote & Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
Processa Pharmaceuticals CAO Wendy Guy buys $4,700 in stock By Investing.com - Investing.com India
Processa Pharmaceuticals CAO Wendy Guy buys $4,700 in stock - Investing.com
Insider Buying: Russell Skibsted Acquires Additional Shares of P - GuruFocus
Processa Pharmaceuticals’ pres. David Young buys $4,590 in stock By Investing.com - Investing.com India
Processa Pharmaceuticals chief business and strategy officer buys $4,065 in stock - Investing.com Nigeria
Processa Pharmaceuticals’ pres. David Young buys $4,590 in stock - Investing.com
Processa Pharmaceuticals (PCSA) R&D chief buys 1,786 shares at $2.57 - Stock Titan
Processa Pharmaceuticals (PCSA) CFO adds 2,292 shares in open-market buy - Stock Titan
Processa (NASDAQ: PCSA) CEO adds 2,129 shares in open-market buy - Stock Titan
Processa (NASDAQ: PCSA) officer adds to stake with share purchase - Stock Titan
Processa (PCSA) CAO Wendy Guy adds 1,829 shares in open-market buy - Stock Titan
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Guy Wendy - Moomoo
Processa Pharmaceuticals (PCSA) Edges Lower as Biotech Volatility PersistsThe Legal Advocate - The Legal Advocate
Processa Pharmaceuticals (PCSA) Surges 5.75% as Shares Test Key Resistance LevelVolume Spike Alerts - The Legal Advocate
PCSA Q4 2025 Earnings: EPS Misses Estimates Amid Pipeline DevelopmentEarnings Decline Risk - The Legal Advocate
Processa Pharmaceuticals Inc. (PCSA) Q4 2025 Earnings: EPS Misses Estimates as Biotech Focuses on Clinical PipelineConsensus Miss Rate - newsline.com
Processa Pharmaceuticals Inc. (PCSA) Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical Pipeline ProgressesGuidance Downgrade Alert - The Legal Advocate
Processa Pharmaceuticals CAO Wendy Guy buys $4,701 in stock By Investing.com - Investing.com India
Processa Pharmaceuticals CEO George Ng buys $5,473 in stock - Investing.com India
Processa Pharmaceuticals president David Young buys $4,588 in shares - Investing.com India
Processa Pharmaceuticals CEO George Ng buys $5,473 in stock By Investing.com - Investing.com South Africa
Sian Bigora, Processa CDO, buys $5,341 in stock - Investing.com UK
Processa Pharmaceuticals president David Young buys $4,588 in shares By Investing.com - Investing.com Australia
Processa Pharmaceuticals CAO Wendy Guy buys $4,701 in stock - Investing.com
Processa (NASDAQ: PCSA) strategy chief buys 1,369 shares in open market - Stock Titan
Processa (PCSA) CEO adds 1,843 shares and corrects prior Form 4 - Stock Titan
Processa (PCSA) R&D head buys 1,545 shares at $2.97 in open market - Stock Titan
Processa Pharmaceuticals (NASDAQ: PCSA) CAO purchases 1,583 shares and corrects prior Form 4 - Stock Titan
Processa Pharmaceuticals (PCSA) CFO adds 1,984 shares in Form 4 buy - Stock Titan
Processa (NASDAQ: PCSA) CEO George Ng buys 1,843 shares in open market - Stock Titan
Processa Pharmaceuticals (PCSA) CDO buys 1,971 shares in open-market trade - Stock Titan
What Processa Pharmaceuticals PCSA is doing that separates it from the herd Modest Gains 20260507Viral Momentum Stocks - Newser
Processa Pharmaceuticals (PCSA) holder CVI reports 200,000-share stake, 7.0% - Stock Titan
TradingKey - TradingKey
The valuation case for Processa Pharmaceuticals (PCSA) that is hard to ignore (+4.36%) 2026-05-08Gamma Squeeze - The Legal Advocate
Processa Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] Processa Pharmaceuticals, Inc. Quarterly Earnings Report - Stock Titan
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ng George K - Moomoo
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lin Patrick - Moomoo
2025 Executive Compensation, Ownership, and Governance Overview for Heatwurx, Inc. (Now Based in Vero Beach, FL) - minichart.com.sg
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer SKIBSTED RUSSELL - Moomoo
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):